These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 28512139)

  • 1. A genome-wide association meta-analysis on lipoprotein (a) concentrations adjusted for apolipoprotein (a) isoforms.
    Mack S; Coassin S; Rueedi R; Yousri NA; Seppälä I; Gieger C; Schönherr S; Forer L; Erhart G; Marques-Vidal P; Ried JS; Waeber G; Bergmann S; Dähnhardt D; Stöckl A; Raitakari OT; Kähönen M; Peters A; Meitinger T; Strauch K; Kedenko L; Paulweber B; Lehtimäki T; Hunt SC; Vollenweider P; Lamina C; Kronenberg F
    J Lipid Res; 2017 Sep; 58(9):1834-1844. PubMed ID: 28512139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) beyond the kringle IV repeat polymorphism: The complexity of genetic variation in the LPA gene.
    Coassin S; Kronenberg F
    Atherosclerosis; 2022 May; 349():17-35. PubMed ID: 35606073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A genome-wide analysis of DNA methylation identifies a novel association signal for Lp(a) concentrations in the LPA promoter.
    Coassin S; Hermann-Kleiter N; Haun M; Wahl S; Wilson R; Paulweber B; Kunze S; Meitinger T; Strauch K; Peters A; Waldenberger M; Kronenberg F; Lamina C
    PLoS One; 2020; 15(4):e0232073. PubMed ID: 32343731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of LPA Thr3888Pro on lipoprotein(a) and coronary artery disease is modified by the LPA KIV-2 variant 4925G>A.
    Grüneis R; Lamina C; Di Maio S; Schönherr S; Zoescher P; Forer L; Streiter G; Peters A; Gieger C; Köttgen A; Kronenberg F; Coassin S
    Atherosclerosis; 2022 May; 349():151-159. PubMed ID: 35534298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians.
    Khalifa M; Noureen A; Ertelthalner K; Bandegi AR; Delport R; Firdaus WJ; Geethanjali FS; Luthra K; Makemaharn O; Pang RW; Salem AH; Sasaki J; Schiefenhoevel W; Lingenhel A; Kronenberg F; Utermann G; Schmidt K
    Atherosclerosis; 2015 Oct; 242(2):521-8. PubMed ID: 26302166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kringle IV type 2 domain variant 4925G>A causes the elusive association signal of the LPA pentanucleotide repeat.
    Grüneis R; Weissensteiner H; Lamina C; Schönherr S; Forer L; Di Maio S; Streiter G; Peters A; Gieger C; Kronenberg F; Coassin S
    J Lipid Res; 2022 Dec; 63(12):100306. PubMed ID: 36309064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Characterization of a Highly Penetrant Form of Hyperlipoprotein(a)emia Associated With Genetically Elevated Cardiovascular Risk.
    Coassin S; Chemello K; Khantalin I; Forer L; Döttelmayer P; Schönherr S; Grüneis R; Chong-Hong-Fong C; Nativel B; Ramin-Mangata S; Gallo A; Roche M; Muelegger B; Gieger C; Peters A; Zschocke J; Marimoutou C; Meilhac O; Lamina C; Kronenberg F; Blanchard V; Lambert G
    Circ Genom Precis Med; 2022 Apr; 15(2):e003489. PubMed ID: 35133173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between lipoprotein(a) (Lp(a)) levels and Lp(a) genetic variants with coronary artery calcification.
    Pechlivanis S; Mahabadi AA; Hoffmann P; Nöthen MM; Broecker-Preuss M; Erbel R; Moebus S; Stang A; Jöckel KH
    BMC Med Genet; 2020 Mar; 21(1):62. PubMed ID: 32220223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel but frequent variant in LPA KIV-2 is associated with a pronounced Lp(a) and cardiovascular risk reduction.
    Coassin S; Erhart G; Weissensteiner H; Eca Guimarães de Araújo M; Lamina C; Schönherr S; Forer L; Haun M; Losso JL; Köttgen A; Schmidt K; Utermann G; Peters A; Gieger C; Strauch K; Finkenstedt A; Bale R; Zoller H; Paulweber B; Eckardt KU; Hüttenhofer A; Huber LA; Kronenberg F
    Eur Heart J; 2017 Jun; 38(23):1823-1831. PubMed ID: 28444229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants associated with Lp(a) lipoprotein level and coronary disease.
    Clarke R; Peden JF; Hopewell JC; Kyriakou T; Goel A; Heath SC; Parish S; Barlera S; Franzosi MG; Rust S; Bennett D; Silveira A; Malarstig A; Green FR; Lathrop M; Gigante B; Leander K; de Faire U; Seedorf U; Hamsten A; Collins R; Watkins H; Farrall M;
    N Engl J Med; 2009 Dec; 361(26):2518-28. PubMed ID: 20032323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPA gene: interaction between the apolipoprotein(a) size ('kringle IV' repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level.
    Røsby O; Berg K
    J Intern Med; 2000 Jan; 247(1):139-52. PubMed ID: 10672142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein(a) catabolism: a case of multiple receptors.
    McCormick SPA; Schneider WJ
    Pathology; 2019 Feb; 51(2):155-164. PubMed ID: 30595508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a).
    Parson W; Kraft HG; Niederstätter H; Lingenhel AW; Köchl S; Fresser F; Utermann G
    Hum Mutat; 2004 Dec; 24(6):474-80. PubMed ID: 15523644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction. The ECTIM Study.
    Brazier L; Tiret L; Luc G; Arveiler D; Ruidavets JB; Evans A; Chapman J; Cambien F; Thillet J
    Atherosclerosis; 1999 Jun; 144(2):323-33. PubMed ID: 10407493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels.
    Lu W; Cheng YC; Chen K; Wang H; Gerhard GS; Still CD; Chu X; Yang R; Parihar A; O'Connell JR; Pollin TI; Angles-Cano E; Quon MJ; Mitchell BD; Shuldiner AR; Fu M
    Hum Mol Genet; 2015 Apr; 24(8):2390-400. PubMed ID: 25575512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic variants, plasma lipoprotein(a) levels, and risk of cardiovascular morbidity and mortality among two prospective cohorts of type 2 diabetes.
    Qi Q; Workalemahu T; Zhang C; Hu FB; Qi L
    Eur Heart J; 2012 Feb; 33(3):325-34. PubMed ID: 21900290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single nucleotide polymorphisms in exons of the apo(a) kringles IV types 6 to 10 domain affect Lp(a) plasma concentrations and have different patterns in Africans and Caucasians.
    Ogorelkova M; Kraft HG; Ehnholm C; Utermann G
    Hum Mol Genet; 2001 Apr; 10(8):815-24. PubMed ID: 11285247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Mechanistic Insights into the Modulation of Circulating Lipoprotein (a) Concentration by Apolipoprotein E Isoforms.
    Chemello K; Blom DJ; Marais AD; Lambert G; Blanchard V
    Curr Atheroscler Rep; 2022 Jun; 24(6):399-405. PubMed ID: 35355214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration.
    Kraft HG; Köchl S; Menzel HJ; Sandholzer C; Utermann G
    Hum Genet; 1992 Nov; 90(3):220-30. PubMed ID: 1336760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q.
    Ober C; Nord AS; Thompson EE; Pan L; Tan Z; Cusanovich D; Sun Y; Nicolae R; Edelstein C; Schneider DH; Billstrand C; Pfaffinger D; Phillips N; Anderson RL; Philips B; Rajagopalan R; Hatsukami TS; Rieder MJ; Heagerty PJ; Nickerson DA; Abney M; Marcovina S; Jarvik GP; Scanu AM; Nicolae DL
    J Lipid Res; 2009 May; 50(5):798-806. PubMed ID: 19124843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.